P&T
Our
Other
Journal
MediMedia Managed Markets
Managed Care

 

Gonadotrophin Products: Empowering Patients To Choose The Product That Meets Their Needs

Gonadotrophin Products: Empowering Patients To Choose The Product That Meets Their Needs

From a managed care perspective, gonadotropin self-injections may be an effective approach to follicle-stimulating hormone (FSH) therapy. Optimal outcomes with self-administered therapy depend on maximizing adherence, minimizing errors, and controlling pain and stress associated with drug administration, all of which have been shown to benefit from patient education and involvement in choice of therapy. In this single-center study, comprehensive nurse-led training classes on conventional syringe- or pen-injection FSH delivery techniques enabled participants to identify a preferred method, with the majority of patients opting for a device in the form of a disposable follitropin alfa prefilled pen.